Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
The purpose of this study is to collect CSF and blood samples that can be used in future research studies to identify potential biomarkers in blood and cerebrospinal fluid (CSF) collected in Amyotrophic Lateral Sclerosis (ALS) patients.
• Clinical diagnosis of possible, laboratory-supported probable, probable or definite ALS according to modified eL Escorial criteria, suspected ALS according to original el Escorial criteria, or diagnosis of a similar neurodegenerative disorder.
• Willing to provide consent, or assent, if physically unable to consent owing to disease-related muscle weakness.
• No personal history of ALS, ALS-FTD or other motor neuron disease.
• Subjects with family history of ALS, ALS-FTD the affected family member needs to be a first, second, or third degree blood relative.
• Willing to provide consent.